Transforming growth factor-beta-1Alternative Names: TGF-beta-1; Transforming growth factor-beta
Latest Information Update: 14 Nov 2006
At a glance
- Originator Genentech
- Developer Genentech; National Cancer Institute (USA)
- Class Antineoplastics; Antivirals; Growth factors; Nootropics; Transforming growth factors
- Mechanism of Action Transforming growth factor beta1 stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Alzheimer's disease; Atherosclerosis; Cancer; Skin disorders; Systemic lupus erythematosus